In our study, we found both JAK2 and RUNX1-mutated patients had high percentage of BM blast (> 1.5%), BM blast (> 1.5%) adequately predicted OS and PFS respectively (p < 0.0001, p < 0.0001) among LR-MDS patients. The gene discussed is JAK2; the disease is myelodysplastic syndrome.